PerpEquities

Equity · Healthcare

Intuitive Surgical, Inc. (ISRG) perpetual futures

ISRG perpetual futures on 9 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ISRGUSDT.

Intuitive Surgical develops and sells robotic surgical systems like the da Vinci and Ion, along with instruments and support services.

$406.89+3.6%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (ISRG-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

9/9 live markets
Venues
9
Live markets
9/9
24h volume
$450.2KCoverage: 8/9 marketsExchange-reported volume: $1.7M
Open interest
$6.7MCoverage: 8/9 markets
Best liquidity
$314.4K
MEXC
Tightest spread
+6.9 bps
OKX
Highest volume
$142.9K
MEXC
Settlement mix
USDT · 7/9
Perp/spot vol.
0.01x
Spot volume $45.3M
OI / float
0.00%
Float $142.9B
Spot performance
1D+0.65%
5D-3.32%
1M+7.58%
6M-12.84%
YTD-30.35%
1Y-12.28%

Venue matrix

9 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeISRG/USDTTrading$406.89+79.1% APR
+0.072% every 8h
+38.1 bps$314.4K$142.9K$6.3MUSDT20x
OKXTradeISRG/USDTTrading$407.18+4.4% APR
+0.00400% every 8h
+6.9 bps$6.3K$138K$105.6KUSDT10x
HTXTradeISRG/USDTTrading$406.60+11.0% APR
+0.010% every 8h
+296.8 bps$0$53.9K$5KUSDT-
BybitTradeISRG/USDTTrading$407.000.0% APR
0.000% every 8h
+14.0 bps$3.5K$47.4K$51.2KUSDT25x
Helix (Injective)TradeISRG/USDCTrading$406.71+24.1% APR
+0.00275% every 1h
--$41.2K-USDC12x
BitgetTradeISRG/USDTTrading$406.630.0% APR
0.000% every 8h
+53.9 bps-$23.3K$74.8KUSDT20x
Gate.ioTradeISRG/USDTTrading$407.800.0% APR
0.000% every 8h
+71.1 bps$10.2K$3.5K$166.7KUSDT20x
ExtendedTradeISRG/USDTrading$406.67+4.4% APR
+0.00050% every 1h
+21.1 bps$200K$0$0USD10x
BingXTradeISRG-USDTTrading$407.32+69.9% APR
+0.064% every 8h
+12.3 bps$8.1K$1.2M⚠$3.7KUSDT-

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Adequate liquidity · 4 of 9 venues absorb $10k · Typical cost: +25.9 bps – +114.7 bps

Cheapest execution: Extended · +16.2 bps

Too thin: OKX, Bybit

No fresh book data: HTX, Helix (Injective), Bitget

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

ISRG

Tightest spread

ISRG

Highest volume

ISRG

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 1h ago
Market cap
$143.6B
Updated 1h ago
Revenue
$11B
Trailing 12 months
Revenue growth
+17%
Next fiscal year
Profit margin
+28.4%
P/E
45.9
Peer P/E 25.9
Free cash flow
$3.2B
Trailing 12 months
More metrics
Net income
$3.1B
Trailing 12 months
P/S
13.0
Peer P/E
25.9
Similar listed perps
Revenue estimate
$11.8B
Next fiscal year
Earnings
2026-10-20
Revenue est. $2.9B · Updated 1h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$10.1B
Net margin+28.4%
Free cash flow$2.5B
Net debt-$3.1B
2020$4.4B
2021$5.7B
2022$6.2B
2023$7.1B
2024$8.4B
2025$10.1B
PeriodRevenueGrowthNet incomeFCF
2020$4.4B-3%$1.1B$1.1B
2021$5.7B+31%$1.7B$1.7B
2022$6.2B+9%$1.3B$958.4M
2023$7.1B+14%$1.8B$749.6M
2024$8.4B+17%$2.3B$1.3B
2025$10.1B+21%$2.9B$2.5B
PeriodGross marginOperating marginNet marginROEROA
2020+65.6%+24.1%+24.3%+10.9%+9.5%
2021+69.3%+31.9%+29.9%+14.3%+12.6%
2022+67.4%+25.3%+21.3%+12.0%+10.2%
2023+66.4%+24.8%+25.2%+13.5%+11.6%
2024+67.5%+28.1%+27.8%+14.1%+12.3%
2025+66.0%+29.3%+28.4%+16.0%+13.8%
PeriodCashDebtNet debtCurrent ratio
2020$1.6B$0-$1.6B6.86
2021$1.3B$87M-$1.2B5.08
2022$1.6B$0-$1.6B4.40
2023$2.8B$0-$2.8B4.76
2024$2B$146M-$1.9B4.07
2025$3.4B$302.8M-$3.1B4.87
PeriodMarket capEnterprise valueP/SP/E
2020$95.7B$94.1B22.090.3
2021$127.9B$126.7B22.475.0
2022$94.4B$92.8B15.271.3
2023$118.5B$115.7B16.665.9
2024$185.4B$183.5B22.279.8
2025$202.1B$199.1B20.170.8
Q3 2024$2B
Q4 2024$2.4B
Q1 2025$2.3B
Q2 2025$2.4B
Q3 2025$2.5B
Q4 2025$2.9B
Q1 2026$2.8B
Q2 2026$2.9B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$2B+17%$565.1M$458.6M
Q4 2024$2.4B+25%$685.7M$510.6M
Q1 2025$2.3B+19%$698.4M$465M
Q2 2025$2.4B+21%$658.4M$560.1M
Q3 2025$2.5B+23%$704.4M$735.6M
Q4 2025$2.9B+19%$794.8M$730M
Q1 2026$2.8B+23%$821.5M$808.6M
Q2 2026$2.9B+19%$818.1M$948.4M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+67.4%+28.3%+27.7%+3.6%+3.2%
Q4 2024+68.0%+30.4%+28.4%+4.2%+3.6%
Q1 2025+64.7%+25.7%+31.0%+4.1%+3.6%
Q2 2025+66.3%+30.5%+27.0%+3.7%+3.3%
Q3 2025+66.4%+30.3%+28.1%+4.2%+3.6%
Q4 2025+66.4%+30.2%+27.7%+4.5%+3.9%
Q1 2026+66.1%+30.9%+29.6%+4.7%+4.1%
Q2 2026+67.8%+33.6%+28.3%+4.5%+3.9%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$2.4B$0-$2.4B4.30
Q4 2024$2B$146M-$1.9B4.07
Q1 2025$2.6B$0-$2.6B4.98
Q2 2025$3.4B$0-$3.4B5.17
Q3 2025$2.8B$0-$2.8B4.73
Q4 2025$3.4B$302.8M-$3.1B4.87
Q1 2026$2B$0-$2B6.03
Q2 2026$2.8B$0-$2.8B4.96
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$174.8B$172.4B85.877.2
Q4 2024$186B$184.1B77.168.0
Q1 2025$177.1B$174.5B78.663.5
Q2 2025$194.8B$191.4B79.873.8
Q3 2025$159.5B$156.7B63.756.5
Q4 2025$201B$197.9B70.163.2
Q1 2026$163.6B$161.6B59.049.9
Q2 2026$141B$138.2B48.742.9

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$2.9BQ2 2026
$723.1M$1.4B$2.2B$2.9BQ3 2023: $1.7BQ4 2023: $1.9BQ1 2024: $1.9BQ2 2024: $2BQ3 2024: $2BQ4 2024: $2.4BQ1 2025: $2.3BQ2 2025: $2.4BQ3 2025: $2.5BQ4 2025: $2.9BQ1 2026: $2.8BQ2 2026: $2.9BQ3 2023Q2 2026
Net income$818.1MQ2 2026
$205.4M$410.8M$616.1M$821.5MQ3 2023: $415.7MQ4 2023: $606.2MQ1 2024: $544.9MQ2 2024: $526.9MQ3 2024: $565.1MQ4 2024: $685.7MQ1 2025: $698.4MQ2 2025: $658.4MQ3 2025: $704.4MQ4 2025: $794.8MQ1 2026: $821.5MQ2 2026: $818.1MQ3 2023Q2 2026
EBITDA$1.2BQ2 2026
$294.1M$588.3M$882.4M$1.2BQ3 2023: $630.6MQ4 2023: $639.1MQ1 2024: $647.8MQ2 2024: $766.3MQ3 2024: $787.2MQ4 2024: $934.5MQ1 2025: $809.4MQ2 2025: $987.4MQ3 2025: $1BQ4 2025: $1.2BQ1 2026: $1.1BQ2 2026: $1.2BQ3 2023Q2 2026
Free cash flow$948.4MQ2 2026
$81.7M$370.6M$659.5M$948.4MQ3 2023: $292.1MQ4 2023: -$207.2MQ1 2024: $23.5MQ2 2024: $311.1MQ3 2024: $458.6MQ4 2024: $510.6MQ1 2025: $465MQ2 2025: $560.1MQ3 2025: $735.6MQ4 2025: $730MQ1 2026: $808.6MQ2 2026: $948.4MQ3 2023Q2 2026
EPS$2.35Q2 2026
$0.59$1.18$1.76$2.35Q3 2023: $1.16Q4 2023: $1.69Q1 2024: $1.51Q2 2024: $1.46Q3 2024: $1.56Q4 2024: $1.88Q1 2025: $1.92Q2 2025: $1.81Q3 2025: $1.95Q4 2025: $2.21Q1 2026: $2.28Q2 2026: $2.35Q3 2023Q2 2026
Cash / Debt$2.8BQ2 2026
$900.5M$1.8B$2.7B$3.6BQ3 2023 · Cash: $3.6BQ3 2023 · Debt: $0Q4 2023 · Cash: $2.8BQ4 2023 · Debt: $0Q1 2024 · Cash: $2.8BQ1 2024 · Debt: $0Q2 2024 · Cash: $3BQ2 2024 · Debt: $0Q3 2024 · Cash: $2.4BQ3 2024 · Debt: $0Q4 2024 · Cash: $2BQ4 2024 · Debt: $146MQ1 2025 · Cash: $2.6BQ1 2025 · Debt: $0Q2 2025 · Cash: $3.4BQ2 2025 · Debt: $0Q3 2025 · Cash: $2.8BQ3 2025 · Debt: $0Q4 2025 · Cash: $3.4BQ4 2025 · Debt: $302.8MQ1 2026 · Cash: $2BQ1 2026 · Debt: $0Q2 2026 · Cash: $2.8BQ2 2026 · Debt: $0Q3 2023Q2 2026
CashDebt
Profitability+67.8%Q2 2026
+17.1%+34.1%+51.2%+68.3%Q3 2023 · Gross margin: +66.9%Q4 2023 · Gross margin: +66.2%Q1 2024 · Gross margin: +65.9%Q2 2024 · Gross margin: +68.3%Q3 2024 · Gross margin: +67.4%Q4 2024 · Gross margin: +68.0%Q1 2025 · Gross margin: +64.7%Q2 2025 · Gross margin: +66.3%Q3 2025 · Gross margin: +66.4%Q4 2025 · Gross margin: +66.4%Q1 2026 · Gross margin: +66.1%Q2 2026 · Gross margin: +67.8%Q3 2023 · Operating margin: +26.7%Q4 2023 · Operating margin: +23.3%Q1 2024 · Operating margin: +24.8%Q2 2024 · Operating margin: +28.2%Q3 2024 · Operating margin: +28.3%Q4 2024 · Operating margin: +30.4%Q1 2025 · Operating margin: +25.7%Q2 2025 · Operating margin: +30.5%Q3 2025 · Operating margin: +30.3%Q4 2025 · Operating margin: +30.2%Q1 2026 · Operating margin: +30.9%Q2 2026 · Operating margin: +33.6%Q3 2023 · Net margin: +23.8%Q4 2023 · Net margin: +31.4%Q1 2024 · Net margin: +28.8%Q2 2024 · Net margin: +26.2%Q3 2024 · Net margin: +27.7%Q4 2024 · Net margin: +28.4%Q1 2025 · Net margin: +31.0%Q2 2025 · Net margin: +27.0%Q3 2025 · Net margin: +28.1%Q4 2025 · Net margin: +27.7%Q1 2026 · Net margin: +29.6%Q2 2026 · Net margin: +28.3%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+18.5%Q2 2026
+6.3%+12.6%+18.9%+25.2%Q2 2024: +14.5%Q3 2024: +16.9%Q4 2024: +25.2%Q1 2025: +19.2%Q2 2025: +21.4%Q3 2025: +22.9%Q4 2025: +18.8%Q1 2026: +23.0%Q2 2026: +18.5%Q3 2023Q2 2026
Shares outstanding358.5MQ2 2026
91.2M182.3M273.5M364.6MQ3 2023: 358.2MQ4 2023: 358.2MQ1 2024: 360.5MQ2 2024: 361MQ3 2024: 362.7MQ4 2024: 363.9MQ1 2025: 364.6MQ2 2025: 364.1MQ3 2025: 361.8MQ4 2025: 360.4MQ1 2026: 359.8MQ2 2026: 358.5MQ3 2023Q2 2026
Valuation42.9Q2 2026
21.442.964.385.8Q3 2023 · P/E: 61.9Q4 2023 · P/E: 49.0Q1 2024 · P/E: 64.1Q2 2024 · P/E: 73.7Q3 2024 · P/E: 77.2Q4 2024 · P/E: 68.0Q1 2025 · P/E: 63.5Q2 2025 · P/E: 73.8Q3 2025 · P/E: 56.5Q4 2025 · P/E: 63.2Q1 2026 · P/E: 49.9Q2 2026 · P/E: 42.9Q3 2023 · P/S: 59.0Q4 2023 · P/S: 61.6Q1 2024 · P/S: 73.8Q2 2024 · P/S: 77.1Q3 2024 · P/S: 85.8Q4 2024 · P/S: 77.1Q1 2025 · P/S: 78.6Q2 2025 · P/S: 79.8Q3 2025 · P/S: 63.7Q4 2025 · P/S: 70.1Q1 2026 · P/S: 59.0Q2 2026 · P/S: 48.7Q3 2023Q2 2026
P/EP/S
Revenue$10.1B2025
$2.5B$5B$7.5B$10.1B2018: $3.7B2019: $4.5B2020: $4.4B2021: $5.7B2022: $6.2B2023: $7.1B2024: $8.4B2025: $10.1B20182025
Net income$2.9B2025
$714M$1.4B$2.1B$2.9B2018: $1.1B2019: $1.4B2020: $1.1B2021: $1.7B2022: $1.3B2023: $1.8B2024: $2.3B2025: $2.9B20182025
EBITDA$4B2025
$997.1M$2B$3B$4B2018: $1.3B2019: $1.6B2020: $1.3B2021: $2.2B2022: $2B2023: $2.4B2024: $3.1B2025: $4B20182025
Free cash flow$2.5B2025
$622.7M$1.2B$1.9B$2.5B2018: $982.2M2019: $1.2B2020: $1.1B2021: $1.7B2022: $958.4M2023: $749.6M2024: $1.3B2025: $2.5B20182025
EPS$7.872025
$1.97$3.94$5.9$7.872018: $3.162019: $3.852020: $2.942021: $4.662022: $3.652023: $5.032024: $6.422025: $7.8720182025
Cash / Debt$3.4B2025
$842M$1.7B$2.5B$3.4B2018 · Cash: $857.9M2018 · Debt: $02019 · Cash: $1.2B2019 · Debt: $76.4M2020 · Cash: $1.6B2020 · Debt: $02021 · Cash: $1.3B2021 · Debt: $87M2022 · Cash: $1.6B2022 · Debt: $02023 · Cash: $2.8B2023 · Debt: $02024 · Cash: $2B2024 · Debt: $146M2025 · Cash: $3.4B2025 · Debt: $302.8M20182025
CashDebt
Profitability+66.0%2025
+17.5%+35.0%+52.4%+69.9%2018 · Gross margin: +69.9%2019 · Gross margin: +69.4%2020 · Gross margin: +65.6%2021 · Gross margin: +69.3%2022 · Gross margin: +67.4%2023 · Gross margin: +66.4%2024 · Gross margin: +67.5%2025 · Gross margin: +66.0%2018 · Operating margin: +32.2%2019 · Operating margin: +30.7%2020 · Operating margin: +24.1%2021 · Operating margin: +31.9%2022 · Operating margin: +25.3%2023 · Operating margin: +24.8%2024 · Operating margin: +28.1%2025 · Operating margin: +29.3%2018 · Net margin: +30.3%2019 · Net margin: +30.8%2020 · Net margin: +24.3%2021 · Net margin: +29.9%2022 · Net margin: +21.3%2023 · Net margin: +25.2%2024 · Net margin: +27.8%2025 · Net margin: +28.4%20182025
Gross marginOperating marginNet margin
Revenue growth+20.5%2025
+5.7%+14.2%+22.6%+31.0%2019: +20.3%2020: -2.7%2021: +31.0%2022: +9.0%2023: +14.5%2024: +17.2%2025: +20.5%20182025
Shares outstanding362.7M2025
91.5M182.9M274.4M365.8M2018: 356.4M2019: 358.5M2020: 360.9M2021: 365.8M2022: 362M2023: 357.4M2024: 362M2025: 362.7M20182025
Valuation70.82025
22.645.167.790.32018 · P/E: 48.22019 · P/E: 49.52020 · P/E: 90.32021 · P/E: 75.02022 · P/E: 71.32023 · P/E: 65.92024 · P/E: 79.82025 · P/E: 70.82018 · P/S: 14.62019 · P/S: 15.22020 · P/S: 22.02021 · P/S: 22.42022 · P/S: 15.22023 · P/S: 16.62024 · P/S: 22.22025 · P/S: 20.120182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-20
Revenue est. $2.9B · Updated 1h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202610.80$11.8B+17%17
FY 202712.08$13.3B+32%17
FY 202813.60$15B+49%8
FY 202915.57$16.8B+67%5
FY 203016.92$18.4B+83%5
Q1 20272.80$3.1B+12%8

Company events

6
2026-10-20EarningsActual - / Estimate 2.64-
2026-07-16EarningsActual 2.8 / Estimate 2.48Beat
2026-04-21EarningsActual 2.8 / Estimate 2.51Beat
2026-01-22EarningsActual 2.53 / Estimate 2.27Beat
2025-10-21EarningsActual 2.4 / Estimate 1.99Beat
2025-07-22EarningsActual 2.19 / Estimate 1.93Beat

Peer comparison

Similar listed perps

FMP company data

Company intelligence

Updated: Oct 5, 2026, 09:44 PM UTC

Company profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
David J. Rosa
Employees
17,021
IPO date
Jun 16, 2000
Country
US
Exchange
NASDAQ Global Select
Website
Altman Z-scorei34.23
Piotroski scorei7/9
FMP ratingiB-
Owner earningsi$1.15B$3.21 per share
ESG risk ratingiB-Industry rank: 53 out of 55

Rating factors

Return on equityi
4
Return on assetsi
5
Debt to equityi
1
Price to earningsi
1
Price to booki
1
Market cap history
$138.95B-9.5%Jul 26 – Oct 26
$124.13B$138.87B$153.61BHigh: $153.61B · 2026-07-06Low: $124.13B · 2026-09-08Latest: $138.95B · 2026-10-02Jul 26Aug 26Sep 26Oct 26
Latest: $138.95B · 2026-10-02High: $153.61B · 2026-07-06Low: $124.13B · 2026-09-08
Largest fund holders
FundWeightShares held
VTI0.18%11.3M
VOO0.2%9.4M
QQQ0.57%7.4M
IVV0.22%4.7M
XAW.TO0.13%4.7M
1557.T0.21%4.4M
SPY0.21%4.3M
FXAIX0.19%3.9M
VUG0.37%3.8M
XLV2.35%2.5M
VGHAX2.37%2.3M
VIIIX0.2%1.9M

Analyst track record

How the analysts covering ISRG have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings152466
Analysts3035
Buy / hold / sell128 / 23 / 1389 / 73 / 4
Upgrades / downgrades / initiations5 / 2 / 39 / 5 / 6
Price targets hit / missed3 / 132 (2%)55 / 351 (14%)
Avg. return after a rating (TipRanks)-29.0%-21.0%
Best / worst call+9.6% / -46.5%+51.4% / -46.5%

After buy calls on this stock: median 21-day move +2.0% vs S&P 500 +1.0% (n = 387)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Ryan ZimmermanBTIG93% hit rate on this stock · 30 targets measuredBuytarget $469Sep 7, 2026
  2. Larry BiegelsenWells Fargo80% hit rate on this stock · 25 targets measuredBuytarget $487Jul 23, 2026
  3. Mike KratkyLeerink Partners79% hit rate on this stock · 14 targets measuredBuytarget $454Jul 17, 2026

Latest ratings

DateAnalystCallTarget
Oct 5, 2026Joanne WuenschCitiBuyMaintained$500
Oct 5, 2026Joanne WuenschCitiBuyMaintained$500
Oct 1, 2026Kendall AuRBC CapitalBuyMaintained$575
Sep 21, 2026Travis SteedBank of America SecuritiesBuyMaintained$470
Sep 21, 2026Travis SteedBank of America SecuritiesBuyMaintained$470
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$350$400$450$500$550$600$650Nov 25 · Buy 16 · Hold 4 · Sell 1Nov 25Dec 25 · Buy 15 · Hold 5 · Sell 1Jan 26 · Buy 17 · Hold 5 · Sell 1Jan 26Feb 26 · Buy 17 · Hold 5 · Sell 0Mar 26 · Buy 18 · Hold 5 · Sell 0Mar 26Apr 26 · Buy 16 · Hold 6 · Sell 0May 26 · Buy 16 · Hold 7 · Sell 0May 26Jun 26 · Buy 16 · Hold 7 · Sell 1Jul 26 · Buy 21 · Hold 7 · Sell 1Jul 26Aug 26 · Buy 22 · Hold 7 · Sell 1Sep 26 · Buy 22 · Hold 5 · Sell 1Sep 26Oct 26 · Buy 22 · Hold 5 · Sell 1Nov 25 · avg. target $612Dec 25 · avg. target $615Jan 26 · avg. target $633Feb 26 · avg. target $642Mar 26 · avg. target $632Apr 26 · avg. target $588May 26 · avg. target $588Jun 26 · avg. target $570Jul 26 · avg. target $499Aug 26 · avg. target $498Sep 26 · avg. target $497Oct 26 · avg. target $497Nov 25 · month-end close $573Dec 25 · month-end close $566Jan 26 · month-end close $504Feb 26 · month-end close $504Mar 26 · month-end close $461Apr 26 · month-end close $458May 26 · month-end close $425Jun 26 · month-end close $398Jul 26 · month-end close $353Aug 26 · month-end close $377Sep 26 · month-end close $407Oct 26 · month-end close $392

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 5, 2026 · 152 ratings

Frequently asked questions

Where can I trade ISRG perpetual futures?

Intuitive Surgical, Inc. (ISRG) perpetual futures trade on 9 crypto venues, including BingX, MEXC, OKX. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade ISRG around the clock?

Yes. Unlike the underlying stock, ISRG perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on ISRG perpetuals?

Right now the ISRG perp funding rate is +4.4% annualized (venue median), ranging from 0.0% to +79.1% across 9 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the ISRG perp price compare to the Intuitive Surgical, Inc. stock?

The venue-median ISRG perp mark is $406.9 versus a reference stock price of $406.9, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a ISRG perpetual future?

A ISRG perpetual is a derivative that tracks the price of Intuitive Surgical, Inc. with no expiry date. It lets you take long or short exposure to Intuitive Surgical, Inc. on crypto venues, around the clock.

What is ISRGUSDT perpetual?

ISRGUSDT is the symbol most crypto exchanges use for the Intuitive Surgical, Inc. perpetual settled in USDT (Tether). It tracks the ISRG share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

ISRG perpetuals · perpequities.comISRG perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/isrg-perp"><img src="https://perpequities.com/badge/isrg-perp.svg" width="240" height="64" alt="ISRG perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of ISRG perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ISRG — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ISRG, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X